| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Quanterix Corp | 56% | -0.54% | $38,811,973 | +$3,615,179 | 30,560,609 | +10% | Quanterix Corporation | 28 Apr 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Akoya Biosciences, Inc. - Common Stock, $0.00001 par value per share (AKYA). This represents 0% of the company’s total 54,965,124 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$16,297,785 | $1.29 | 0 |
| 2025 Q2 | 12,538,172 | $16,299,458 | +$393,906 | $1.30 | 57 |
| 2025 Q1 | 12,180,731 | $16,933,516 | -$396,175 | $1.39 | 64 |
| 2024 Q4 | 12,134,199 | $27,787,012 | -$94,780 | $2.29 | 60 |
| 2024 Q3 | 12,090,894 | $32,886,405 | -$636,504 | $2.72 | 59 |
| 2024 Q2 | 12,385,236 | $28,979,719 | -$9,287,172 | $2.34 | 58 |
| 2024 Q1 | 14,854,113 | $69,665,707 | +$272,730 | $4.69 | 66 |
| 2023 Q4 | 14,746,467 | $72,097,557 | -$6,143,228 | $4.88 | 62 |
| 2023 Q3 | 16,048,557 | $74,626,912 | -$4,377,853 | $4.65 | 60 |
| 2023 Q2 | 16,061,952 | $118,696,041 | +$17,919,115 | $7.39 | 72 |
| 2023 Q1 | 13,357,367 | $109,090,839 | -$6,745,365 | $8.18 | 63 |
| 2022 Q4 | 14,068,910 | $134,634,613 | -$3,380,379 | $9.57 | 71 |
| 2022 Q3 | 14,383,053 | $169,004,351 | +$16,199,753 | $11.75 | 55 |
| 2022 Q2 | 12,982,721 | $166,825,000 | +$9,078,280 | $12.85 | 52 |
| 2022 Q1 | 12,312,165 | $135,320,000 | -$258,605 | $10.99 | 45 |
| 2021 Q4 | 12,136,619 | $189,431,000 | +$26,498,236 | $15.31 | 44 |
| 2021 Q3 | 9,884,433 | $137,984,289 | -$15,853,081 | $13.96 | 46 |
| 2021 Q2 | 10,064,753 | $194,653,000 | +$194,653,002 | $19.34 | 60 |